Nabp-logo
Icon-eprofile e-Profile Login and ID Quick Search
home about programs publications news meetings contact
boards of pharmacy members pharmacists students technicians government affairs consumers

Potential Signals of Serious Risks/New Safety Information from AERS Updates

September 9, 2010 2:31 pm

FDA has updated its Web page reporting potential signals of serious risks and new safety information identified from the Adverse Event Reporting System between April and June 2010. For the drugs included, FDA has identified a potential safety issue, not a causal relationship, between the drug and the reported risk. FDA emphasizes that the report should not be used to advise patients to stop taking the medications listed.

  • FDA Podcast Provides Information on Admini...
  • Main
  • Canadian Man Sentenced In US Court for Sel...
Sign up to receive NABP e-News Sign up to receive AWARxE News

News Topics

  • Compounding
  • Controlled substances
  • Counterfeit drugs
  • Buying medicine online
  • Committee and task force reports
  • Continuing education
  • Diversion
  • Education
  • Electronic prescriptions
  • Federal regulations
  • Internet pharmacy
  • Medication collection program disposal
  • Over the counter
  • Patient safety
  • Pharmacies
  • Pharmacists
  • Pharmacy technicians
  • Practitioner prescriber
  • Prescribing authority
  • Prescription drug abuse
  • Prescription label
  • Prescription monitoring program
  • Prescriptions
  • Pseudoephedrine
  • Resolutions
  • Tamper resistant prescription
  • Vaccinations

Archives

  • April 2013 (27)
  • March 2013 (21)
  • February 2013 (20)
  • January 2013 (26)
  • 2012 (303)
  • 2011 (359)
  • 2010 (301)
  • 2009 (189)
  • 2008 (188)
  • 2007 (215)
  • 2006 (164)
  • 2005 (53)
  • 2004 (62)
  • 2003 (43)
  • 2002 (37)
  • 2001 (31)

Copyright © 2013 National Association of Boards of Pharmacy® (NABP®).

  • Resources
  • Terms of Use Statement
  • Privacy Policy
  • Linking Policy
NABP